...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Orphan Disease Announcement
2
Sep 24, 2015 07:06AM
3
Sep 24, 2015 07:12AM
5
Sep 24, 2015 08:23AM
2
Sep 24, 2015 08:30AM

I don't know the timing.

Regarding the FDA this is where it goes beyond my knowledge. For the PNH orphan indication RVX is using the RVX-208 molecule which is also being used in the BOM trial. I do not understand the regulatory considerations when trials are being conducted with the same drug but for different indications.

3
Sep 24, 2015 08:54AM
7
Sep 24, 2015 06:41PM
2
Sep 24, 2015 08:13PM
Share
New Message
Please login to post a reply